Faculty Profiles - MATSUSHITA, Tadashi

Papers - MATSUSHITA, Tadashi

Division display 101 - 120 of about 231 ／ All the affair displays >>

Newly diagnosed multiple myeloma with bleeding and coagulation abnormalities caused by a thrombin-inhibiting substance

Ohara, F; Suzuki, A; Suzuki, N; Kanematsu, T; Okamoto, S; Tamura, S; Kiyoi, H; Matsushita, T; Katsumi, A

INTERNATIONAL JOURNAL OF HEMATOLOGY 2024.9

Variability in combinations of APTT reagent and substrate plasma for a one-stage clotting assay to measure factor VIII products

Suzuki, A; Suzuki, N; Kanematsu, T; Okamoto, S; Suzuki, N; Tamura, S; Kikuchi, R; Katsumi, A; Kojima, T; Matsushita, T

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY Vol. 46 ( 4 ) page： 705 - 713 2024.8

Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial

Kenet, G; Nolan, B; Fikar, BZ; Antmen, B; Kampmann, P; Matsushita, T; You, CW; Vilchevska, K; Bagot, CN; Sharif, A; Peyvandi, F; Young, G; Negrier, C; Chi, JR; Kittner, B; Sussebach, C; Shammas, F; Mei, BS; Andersson, S; Kavakli, K

BLOOD Vol. 143 ( 22 ) page： 2256 - 2269 2024.5

Florigen-producing cells express FPF1-LIKE PROTEIN 1 that accelerates flowering and stem growth in long days with sunlight red/far-red ratio in Arabidopsis.

Takagi H, Lee N, Hempton AK, Purushwani S, Notaguchi M, Yamauchi K, Shirai K, Kawakatsu Y, Uehara S, Albers WG, Downing BLR, Ito S, Suzuki T, Matsuura T, Mori IC, Mitsuda N, Kurihara D, Matsushita T, Song YH, Sato Y, Nomoto M, Tada Y, Hanada K, Cuperus JT, Queitsch C, Imaizumi T

bioRxiv : the preprint server for biology 2024.4

Real-world effectiveness and safety of damoctocog alfa pegol in patients with haemophilia A and a history of factor VIII inhibitors: A post-hoc analysis of the ongoing HEM-POWR study

Reding, M; Alvarez-Román, MT; Castaman, G; Janbain, M; Matsushita, T; Meijer, K; Schmidt, K; Oldenburg, J

HAEMOPHILIA Vol. 30 page： 34 - 35 2024.4

Basement membrane extract potentiates the endochondral ossification phenotype of bone marrow-derived mesenchymal stem cell-based cartilage organoids

Notoh, H; Yamasaki, S; Suzuki, N; Suzuki, A; Okamoto, S; Kanematsu, T; Suzuki, N; Katsumi, A; Kojima, T; Matsushita, T; Tamura, S

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Vol. 701 page： 149583 2024.3

Surgical procedures and haemostatic outcome in patients with haemophilia receiving concizumab prophylaxis during the phase 3 explorer7 and explorer8 trials

Lopez-Jaime, FJ; Barnes, C; Chan, AKC; Linari, S; Matsushita, T; Bovet, J; Odgaard-Jensen, J; Poulsen, LH

HAEMOPHILIA Vol. 30 page： 66 - 67 2024.2

HEM-POWR study interim analysis four: Effectiveness of damoctocog alfa pegol treatment for previously treated patients with haemophilia A

Reding, MT; Román, MTA; Castaman, G; Janbain, M; Matsushita, T; Meijer, K; Schmidt, K; Oldenburg, J

HAEMOPHILIA Vol. 30 page： 105 - 106 2024.2

Interim analyses of the multinational real-world prospective cohort HEM-POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A

Reding, MT; Alvarez-Román, MT; Castaman, G; Janbain, M; Matsushita, T; Meijer, K; Schmidt, K; Oldenburg, J

EUROPEAN JOURNAL OF HAEMATOLOGY Vol. 112 ( 2 ) page： 286 - 295 2024.2

Safety profile of damoctocog alfa pegol: Fourth interim analysis of the real-world HEM-POWR study for previously treated patients with haemophilia A

Reding, MT; Román, MTA; Castaman, G; Janbain, M; Matsushita, T; Meijer, K; Schmidt, K; Oldenburg, J

HAEMOPHILIA Vol. 30 page： 104 - 105 2024.2

[Biology of von Willebrand factor and pathogenesis of von Willebrand disease].

Matsushita T

[Rinsho ketsueki] The Japanese journal of clinical hematology Vol. 65 ( 8 ) page： 756 - 763 2024

Surgical Procedures and Hemostatic Outcome in Patients with Hemophilia Receiving Concizumab Prophylaxis during the Phase 3 explorer7 and explorer8 Trials

Chan, AKC; Barnes, C; Mathias, M; Linari, S; Jaime, FJL; Poulsen, LH; Bovet, J; Odgaard-Jensen, J; Matsushita, T

BLOOD Vol. 142 2023.11

The immunogenicity, safety, and efficacy of N8-GP in previously untreated patients with severe hemophilia A: pathfinder6 end-of-trial results

Kenet, G; Young, G; Chuansumrit, A; Matsushita, T; Yadav, V; Zak, M; Male, C

JOURNAL OF THROMBOSIS AND HAEMOSTASIS Vol. 21 ( 11 ) page： 3109 - 3116 2023.11

Cases of less-than-expected FVIII activity in previously treated patients during post-marketing surveillance of N8-GP

Oldenburg, J; Benson, G; Chowdary, P; Halimeh, S; Matsushita, T; Norland, A; Wahid, MN; Nemes, L

HAEMOPHILIA Vol. 29 ( 6 ) page： 1475 - 1482 2023.11

Haemophilia and cardiovascular disease in Japan: Low incidence rates from ADVANCE Japan baseline data

Nagao, A; Chikasawa, Y; Sawada, A; Kanematsu, T; Yamasaki, N; Takedani, H; Nojima, M; Fujii, T; Suzuki, N; Matsushita, T; Higasa, S; Amano, K; ADVANCE Japan Working Grp

HAEMOPHILIA Vol. 29 ( 6 ) page： 1519 - 1528 2023.11

Use of nonacog beta pegol during surgery in persons with hemophilia B: a case series

Phua, CW; Matino, D; Kühnöl, CD; Hegemann, I; Matsushita, T

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS Vol. 7 ( 7 ) page： 102208 2023.10

Clinical course and prognosis of patients with hepatocellular carcinoma and haemophilia

Matsuda, N; Imai, N; Yokoyama, S; Yamamoto, K; Ito, T; Ishizu, Y; Honda, T; Okamoto, S; Kanematsu, T; Suzuki, N; Matsushita, T; Ishigami, M; Kawashima, H

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY Vol. 35 ( 10 ) page： 1211 - 1215 2023.10

EFFECTIVENESS AND SAFETY OF DAMOCTOCOG ALFA PEGOL IN PATIENTS WITH HEMOPHILIA A WITH A HISTORY OF FACTOR VIII INHIBITORS: INTERIM ANALYSIS FROM THE REAL-WORLD HEM-POWR STUDY

Castaman, G; Reding, MT; Román, MTA; Janbain, M; Peyvandi, F; Matsushita, T; Meijer, K; Schmidt, K; Oldenburg, J

HAEMOPHILIA Vol. 29 page： 32 - 32 2023.9

Phase 3 Trial of Concizumab in Hemophilia with Inhibitors

Matsushita, T; Shapiro, A; Abraham, A; Angchaisuksiri, P; Castaman, G; Cepo, K; d'Oiron, R; Frei-Jones, M; Goh, AS; Haaning, J; Jacobsen, SH; Mahlangu, J; Mathias, M; Nogami, K; Rasmussen, JS; Stasyshyn, O; Tran, H; Vilchevska, K; Martinez, LV; Windyga, J; You, CW; Zozulya, N; Zulfikar, B; Jiménez-Yuste, V

NEW ENGLAND JOURNAL OF MEDICINE Vol. 389 ( 9 ) page： 783 - 794 2023.8

The efficacy and safety of caplacizumab in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura: an open-label phase 2/3 study

Miyakawa, Y; Imada, K; Ichikawa, S; Uchiyama, H; Ueda, Y; Yonezawa, A; Fujitani, S; Ogawa, Y; Matsushita, T; Asakura, H; Nishio, K; Suzuki, K; Hashimoto, Y; Murakami, H; Tahara, S; Tanaka, T; Matsumoto, M

INTERNATIONAL JOURNAL OF HEMATOLOGY Vol. 117 ( 3 ) page： 366 - 377 2023.3

　 PREV - NEXT 　

<MATSUSHITA, Tadashi>

Papers - MATSUSHITA, Tadashi